EP Patent

EP2599781A1 — Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof

Assigned to Dr Reddys Laboratories Ltd · Expires 2013-06-05 · 13y expired

What this patent protects

There is provided salts and polymorphs of sitagliptin, processes for the preparation thereof, and pharmaceutical compositions comprising the same.

USPTO Abstract

There is provided salts and polymorphs of sitagliptin, processes for the preparation thereof, and pharmaceutical compositions comprising the same.

Drugs covered by this patent

Patent Metadata

Patent number
EP2599781A1
Jurisdiction
EP
Classification
—
Expires
2013-06-05
Drug substance claim
No
Drug product claim
No
Assignee
Dr Reddys Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.